Welcome to our dedicated page for Healthy Extracts news (Ticker: HYEX), a resource for investors and traders seeking the latest updates and insights on Healthy Extracts stock.
Healthy Extracts Inc. (OTCQB: HYEX) generates frequent news as a science-based nutraceutical and oral delivery technology company focused on heart, brain, gut and metabolic health. Company updates often highlight record quarterly net revenue, growth in subscription-based recurring revenue, and developments in its proprietary delivery platforms.
News coverage for HYEX commonly includes earnings and outlook announcements, such as record net revenue quarters and revised annual guidance, as well as details on adjusted EBITDA and cash flow trends. Releases also describe operational milestones, including maintaining a top-three category ranking on Amazon.com for certain products and expanding direct-to-consumer and retail channels.
Another major theme in Healthy Extracts news is corporate transactions and integration. The acquisition and merger of Gummy USA, a precision-dosed nutraceutical gummy manufacturer with a HACCP, GMP-certified and FDA-registered facility, has been covered in detail, including the associated change-of-control events disclosed in Form 8-K filings. Updates describe how this transaction adds in-house manufacturing, SureDose™ technology and new white-label and private-label customers.
Product and technology launches are also frequent topics. Recent releases have introduced STAT10 for statin users, 4Sleep for sleep support, Hydrate EZ™ and Mynus Sugar™ gel-packs using Gelteq technology, and the Whitney Johns Gut Health Straw™ based on functional fiber straw IP. These stories explain how new formulations and delivery systems expand Healthy Extracts’ addressable markets and support its growth roadmap.
Investors following HYEX news can expect coverage of financial performance, mergers and acquisitions, new product categories, white-label wins, and conference presentations at microcap and growth-focused investor events. Bookmark this page to monitor how recurring revenue, exclusive technologies and strategic partnerships shape the company’s ongoing narrative.
Healthy Extracts (OTCQB:HYEX) announced preliminary results for Q2 2024, projecting record net revenue exceeding $900,000, marking a 30% increase from the previous quarter and over 50% compared to Q2 2023. The company also expects a gross margin above 53%, leading to positive operating cash flow and its third consecutive quarter of net profitability, excluding non-core and non-cash expenses. The growth is attributed to substantial direct-to-consumer and wholesale revenue. Additionally, Healthy Extracts paid down more than $100,000 in debt and improved its cash position, forecasting a third cash flow-positive quarter with over $140,000. The company aims to leverage its market channels to launch new products and expand revenue streams throughout the year, enhancing shareholder value.
Healthy Extracts (OTCQB:HYEX) reported first-quarter 2024 financial results. Net revenue rose 12% to $689,000, driven by distribution expansion and subscription revenue growth. Gross margin increased to 59.3% from 45.2%, thanks to improved manufacturing efficiency. The company achieved a positive cash flow of $68,000 for the second consecutive quarter.
Net loss was $861,000 or $(0.30) per share, primarily due to interest expenses and stock-based compensation. Excluding non-core costs, the net income was $2,500. Subscription growth was strong, with Amazon 'Subscribe & Save' customers up 81% and direct-to-consumer subscriptions up 28% year-over-year.
The company plans to launch new products in the latter half of 2024, including anti-aging and sugar blocker gel packs. Healthy Extracts aims for continued growth and profitability in upcoming quarters.
FAQ
What is the current stock price of Healthy Extracts (HYEX)?
What is the market cap of Healthy Extracts (HYEX)?
